Y Combinator is launching a biotech track

 Y Combinator is pulling the curtains off of a new experiment, YC Bio. The idea is to fund early-stage life-sciences companies that are still in the lab phase, YC President Sam Altman wrote on the YC blog today. YC Bio’s first area of focus will be on healthspan and age-related disease. Read More

Responses are currently closed, but you can trackback from your own site.

Comments are closed.